Giuliante, Felice
 Distribuzione geografica
Continente #
EU - Europa 14.792
NA - Nord America 12.800
AS - Asia 9.538
SA - Sud America 1.864
AF - Africa 319
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 39.377
Nazione #
US - Stati Uniti d'America 12.483
IT - Italia 4.787
DE - Germania 4.373
SG - Singapore 4.237
CN - Cina 2.254
BR - Brasile 1.536
SE - Svezia 1.496
VN - Vietnam 966
FR - Francia 907
UA - Ucraina 828
GB - Regno Unito 516
IE - Irlanda 436
IN - India 422
PL - Polonia 332
FI - Finlandia 318
ID - Indonesia 300
JP - Giappone 295
RU - Federazione Russa 227
HK - Hong Kong 172
CA - Canada 168
TR - Turchia 156
BD - Bangladesh 141
AR - Argentina 120
NL - Olanda 101
IQ - Iraq 97
MX - Messico 96
ZA - Sudafrica 92
BE - Belgio 78
AT - Austria 75
ES - Italia 69
MA - Marocco 65
IR - Iran 58
KR - Corea 51
PK - Pakistan 50
EC - Ecuador 45
SA - Arabia Saudita 45
VE - Venezuela 39
CZ - Repubblica Ceca 36
JO - Giordania 36
RO - Romania 34
AU - Australia 33
CL - Cile 31
EG - Egitto 30
PH - Filippine 30
AE - Emirati Arabi Uniti 29
CO - Colombia 27
UZ - Uzbekistan 27
CI - Costa d'Avorio 25
DZ - Algeria 25
KE - Kenya 25
PY - Paraguay 25
CH - Svizzera 24
IL - Israele 24
LT - Lituania 24
MY - Malesia 23
AL - Albania 20
TN - Tunisia 19
GR - Grecia 18
AZ - Azerbaigian 16
UY - Uruguay 15
EU - Europa 14
LU - Lussemburgo 14
NP - Nepal 14
BO - Bolivia 13
PT - Portogallo 11
CR - Costa Rica 10
DK - Danimarca 10
LB - Libano 10
PE - Perù 10
KG - Kirghizistan 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
OM - Oman 9
SN - Senegal 9
TH - Thailandia 9
HN - Honduras 8
KZ - Kazakistan 8
MD - Moldavia 8
BG - Bulgaria 7
PA - Panama 7
DO - Repubblica Dominicana 6
EE - Estonia 6
ET - Etiopia 5
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
LK - Sri Lanka 5
NG - Nigeria 5
QA - Qatar 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BH - Bahrain 4
BW - Botswana 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
AM - Armenia 3
KH - Cambogia 3
MK - Macedonia 3
MM - Myanmar 3
Totale 39.313
Città #
Singapore 2.289
Ashburn 1.847
Chandler 1.840
San Jose 1.137
Rome 438
Beijing 429
Dublin 425
Jacksonville 421
Milan 419
San Mateo 350
New York 345
Ho Chi Minh City 341
Los Angeles 283
Nürnberg 277
Tokyo 260
Jakarta 255
Lauterbourg 253
Nanjing 253
Hanoi 242
Hefei 240
Warsaw 236
Boston 233
Wilmington 203
Ann Arbor 199
Woodbridge 158
Dallas 156
Princeton 152
Hong Kong 147
Munich 146
São Paulo 145
Frankfurt am Main 140
Moscow 138
Houston 126
Cattolica 121
Dearborn 113
Redwood City 108
Naples 107
Izmir 101
Marseille 101
Hyderabad 99
Palermo 99
Seattle 98
Helsinki 92
The Dalles 87
Fairfield 85
Nanchang 82
Chicago 79
Santa Clara 79
Buffalo 78
Brussels 71
Lawrence 68
Orem 68
Kent 65
Bremen 63
Council Bluffs 63
London 63
Augusta 62
Shenyang 62
Kraków 61
Montreal 61
Toronto 56
Boardman 55
Shanghai 55
Denver 54
Catania 52
Rio de Janeiro 52
Stockholm 52
Bari 51
Hangzhou 51
Da Nang 50
Phoenix 50
Bologna 49
Tianjin 47
Amsterdam 46
Atlanta 45
Hebei 45
Nuremberg 45
Seoul 45
Turku 45
Mountain View 44
Johannesburg 43
Paris 43
Vienna 43
Florence 42
University Park 42
Leawood 41
San Francisco 40
St Louis 40
Changsha 39
Guangzhou 39
Belo Horizonte 36
Haiphong 35
Brooklyn 34
Jiaxing 34
Chennai 33
Düsseldorf 33
Poplar 33
Amman 32
Dhaka 32
Napoli 32
Totale 18.494
Nome #
Complicanze biliari della colecistectomia: la gestione della fase acuta delle lesioni iatrogene della via biliare principale 3.975
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
Le lesioni iatrogene della via biliare principale - Associata alla Relazione Biennale su invito al 104° Congresso della Società Italiana di Chirurgia, anno 2002 (Relatore: Gennaro Nuzzo) 534
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 456
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 408
Parenteral nutrition in liver resection 388
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 351
Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence 260
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 251
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 243
Long-term outcome after laparoscopic fenestration of simple liver cysts 242
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 236
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 231
Anatomia del fegato 226
Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases 224
External lymphatic fistula after intra-abdominal lymphadenectomy for cancer. Treatment with total parenteral nutrition and somatostatin 221
Liver resection for intrahepatic cholangiocarcinoma 213
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 213
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 210
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 210
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 204
Hypocholesterolemia in surgical trauma, sepsis, other acute conditions and critical illness 202
Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer 201
La calcolosi intraepatica primaria. Indicazioni e risultati del trattamento chirurgico resettivo. 199
Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer 198
Left hepatectomy for metastatic thrombosis of umbilical vein and left portal vein from renal cell carcinoma 197
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 191
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 191
Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients 190
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 190
Plasma bilirubin correlations in non-obstructive cholestasis after partial hepatectomy 189
La calcolosi intraepatica 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients 185
Hepatic veins in presurgical planning of hepatic resection: what a radiologist should know 184
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 184
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas 178
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 177
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 177
Bile duct injury during laparoscopic cholecystectomy: results of an Italian national survey on 56591 cholecystectomies 175
Giant focal nodular hyperplasia determining Budd-Chiari syndrome: an operative challenge requiring 210 min of liver ischemia 174
Liver resection for primary intrahepatic stones: a single-center experience 174
Easy quantification of the respiratory and metabolic impact of blood O2-CO2 exchange interactions in critical illness 174
Multidisciplinary management of major bile duct injuries occurred during cholecystectomy 172
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 172
Hypocholesterolemia and plasma amino acids in sepsis 171
Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis: a worrisome picture 170
Intraoperative liver ultrasound still affects surgical strategy for patients with colorectal metastases in the modern era 169
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 169
Outcomes comparison of Pancreato-Gastrostomy and Isolated Jejunal Loop Pancreato-Jejunostomy following Pancreato-Duodenectomy in patients with soft pancreas and at moderate-high risk for POPF: a retrospective multicenter experience-based analysis 167
Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients 166
Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically 165
Impairment of hepatocellular excretory function, sepsis and liver insufficiency after liver resection (Letter) 165
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 163
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 162
Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients 159
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Complex liver resection for hepatic tumours involving the inferior vena cava 157
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 157
Plasma cholinesterase correlations in acute surgical and critical illness 156
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 156
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 156
Bases fisiológicas da monitorização cardiorrespiratória 153
Analysis of the components of hypertransaminasemia after liver resection 153
Liver resections for hilar cholangiocarcinoma 153
Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. 153
Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. 152
Liver resection in advanced age 152
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 150
Risk for laparoscopic fenestration of liver cysts 149
An extreme case of Heyde syndrome 149
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 149
Plasma cholesterol (CHOL) in critically ill surgical patients 148
Hypophosphatemia (Hypo-P) after liver resections 147
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 146
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 144
The relationship between plasma albumin, other proteins and variables, and age in the acute phase response after hepatectomy in man 144
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 144
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 144
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments 143
Advantages of multidisciplinary management of bile duct injuries occurring during cholecystectomy 143
Role of intraoperative cholangiography in avoiding bile duct injury (Letter) 143
Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases 142
Pedicle clamping with ischemic preconditioning in liver resection 142
Complications of laparoscopic cholecystectomy 142
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 141
Sepsis after liver resection: Predisposition, clinical relevance and synergism with liver dysfunction 141
Anatomical liver resection of segment 4a en bloc with the caudate lobe 141
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 141
Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients 140
Low cholesterol and outcome after hepatectomy 140
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 139
Hepatectomy and plasma cholinesterase evolution 139
Multicentre evaluation of case volume in minimally invasive hepatectomy 139
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 139
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 139
Hanging maneuver in right hepatectomy for recurrent metastases with diaphragmatic infiltration after radiofrequency ablation: a new indication 138
Liver resection for primary intrahepatic stones: Focus on postoperative infectious complications 138
Totale 22.653
Categoria #
all - tutte 138.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021534 0 0 0 0 0 0 0 0 0 0 416 118
2021/20222.649 182 205 75 214 119 101 77 377 138 200 357 604
2022/20235.800 702 688 486 819 345 648 284 593 638 171 257 169
2023/20243.094 165 676 119 288 138 324 380 339 48 128 173 316
2024/20254.726 94 175 397 188 317 148 182 222 651 510 1.006 836
2025/202612.649 1.950 437 800 1.516 2.314 649 2.404 710 882 954 33 0
Totale 39.875